Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.605, 2010-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
EU evaluation of high-cost orphan drugs urged
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 661, 2012-01 ,pp. :
Access to resources
Recommend
Impact of High‐Cost Drugs for Individual Patient Use
JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 34, Iss. 2, 2004-06 ,pp. :
Access to High‐Cost Drugs: Decision Makers' Perspectives
JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 35, Iss. 1, 2005-03 ,pp. :
Biopharmaceuticals a high-cost gamble
Pharmaceutical & Diagnostic Innovation, Vol. 4, Iss. 11, 2006-01 ,pp. :
Prescribing of high-cost diabetes medications lacks consistency
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 665, 2012-01 ,pp. :